Meeting
Abstract Number: 114
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Procalcitonin (PCT) is a precursor peptide to calcitonin produced by the thyroid parafollicular cells, and the intestinal and lung neuroendocrine cells. PCT is a proinflammatoy marker specific to bacterial infections, and was initially used clinically to guide antibiotic therapy in lower respiratory tract infections. PCT has seen its role expanded to aid with initiation, […]
Abstract Number: 121
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: With standard diagnostic methods, the etiologic pathogen of community acquired pneumonia (CAP) is detected in ≤ 50% hospitalized CAP patients. In our previous studies using a diagnostic “bundle”, we were able to detect etiologic pathogens in ≥ 70 % of the patients. Our bundle consisted of a nasopharyngeal swab for Biofire film array, that […]
Abstract Number: 342
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Blood stream infection is associated with high mortality and morbidity. Blood cultures are considered the gold standard for diagnosing bacteremia in sepsis patients. However, blood culture results may take at least 12 to 24 hours for a positive result and may even be complicated by contamination. Procalcitonin (PCT) a biomarker for bacterial infection is […]
Abstract Number: 362
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Procalcitonin (PCT) is a biomarker that correlates with the presence of bacterial infection in certain clinical scenarios; it has increasingly accepted indications for antibiotic stewardship. Most sources suggest that antibiotics should be considered for patients with suspected infection and PCT values ≥ 0.25-0.5 ng/ml; conversely, clinicians should consider withholding antibiotics for patients with PCT […]